UPDATE 3-Biogen's Spinraza drives third-quarter profit beat
October 23, 2018 at 11:03 AM EDT
* MS drug Tecfidera misses analyst estimates (Adds CEO, analyst comment, share movement, Spinraza details from conference call)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|